Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.940
-0.040 (-2.02%)
Mar 6, 2026, 1:25 PM EST - Market open
Enveric Biosciences Employees
As of December 31, 2024, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,874,319
Market Cap
2.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | -19 | -73.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | 21 | 700.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| Scinai Immunotherapeutics | 31 |
| Dermata Therapeutics | 8 |
| Artelo Biosciences | 5 |
| Oragenics | 5 |
| GRI Bio | 4 |
| 60 Degrees Pharmaceuticals | 3 |
| XORTX Therapeutics | 3 |
ENVB News
- 9 days ago - Enveric Biosciences Announces Withdrawal of Petition Against Its Patent - Business Wire
- 15 days ago - Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data - Business Wire
- 5 weeks ago - Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Business Wire
- 5 weeks ago - Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 5 weeks ago - Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 2 months ago - Enveric Biosciences Announces Patent Issuance - Business Wire
- 2 months ago - Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - Business Wire
- 3 months ago - Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds - Business Wire